Ajooni Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 605.33 million compared to INR 332.32 million a year ago. Revenue was INR 624.7 million compared to INR 332.64 million a year ago. Net income was INR 12.46 million compared to INR 5.85 million a year ago. Basic earnings per share from continuing operations was INR 0.71 compared to INR 0.33 a year ago. Diluted earnings per share from continuing operations was INR 0.71 compared to INR 0.33 a year ago.